Nutritional problems in adult patients with stage 5 chronic kidney disease on dialysis (both haemodialysis and peritoneal dialysis)

NDT Plus

Volumn 3, Issue 2, 2010, Pages 109-117

  Heng, Anne Elisabeth ^a,b   Cano, Noël J M ^a,b,c,d  

^a SERVICE DE RHUMATOLOGIE   (France)

^b CEMAGREF   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d CRNH AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; ASCORBIC ACID; FOLIC ACID; GHRELIN; MEGESTROL ACETATE; PREALBUMIN; PYRIDOXINE; SELENIUM; THIAMINE; VITAMIN D; ZINC;

ALBUMIN BLOOD LEVEL; AMINO ACID METABOLISM; ANOREXIA; CALORIC INTAKE; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INTRADIALYTIC PARENTERAL NUTRITION; KIDNEY FUNCTION; LEAN BODY WEIGHT; MORBIDITY; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL PARAMETERS; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; PROTEIN METABOLISM; REVIEW; TUBE FEEDING; UREMIA;

EID: 77955969345     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp147     Document Type: Review

References (105)

1. Zoccali C. The obesity epidemics in ESRD: from wasting to waist? Nephrol Dial Transplant 2009; 24: 376-380
2. de MutsertR, SnijderMB, VanDerSman-de BeerF etal.Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007; 18: 967-974
3. Aparicio M, Cano N, Chauveau P et al. French Study Group for Nutrition in Dialysis. Nutritional status of haemodialysis patients: a French national cooperative study. Nephrol Dial Transplant 1999; 14:1679-1686
4. Ritz E, Rychlik I, Locatelli F et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999; 34:795-808
5. Cano NJ, Roth H, Aparicio M et al. Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. Kidney Int 2002;62:593-601
6. Wang AY, Sanderson J, Sea MM et al. Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis. Am J Clin Nutr 2003; 77: 834-841
7. Combe C, Chauveau P, Laville M et al. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis 2001; 37: S81-S88
8. National Kidney Foundation (NFK) K/DOQI. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35: S1-S140
9. Toigo G, Aparicio M, Attman PO et al. Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2). Clin Nutr 2000; 19: 281-291
10. Fouque D, Vennegoor M, ter Wee P et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007; 22(Suppl 2): ii45-ii87
11. Dombros N, Dratwa M, Feriani M et al. European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. Nephrol Dial Transplant 2005; 20(Suppl 9): ix28-ix33
12. Cano N, Fiaccadori E, Tesinsky P et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr 2006; 25: 295-310
13. Carrero JJ, Aguilera A, Stenvinkel P et al. Appetite disorders in uremia. J Ren Nutr 2008; 18: 107-113
14. Mamoun AH, Sodersten P, Anderstam B et al. Evidence of splanchnic-brain signaling in inhibition of ingestive behaviorby middle molecules. J Am Soc Nephrol 1999; 10: 309-314
15. Aguilera A, Codoceo R, Selgas R et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plama levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant 1998; 13: 1476-1483
16. Wang AY, Sea MM, Ip R et al. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12: 2450-2457
17. Aguilera A, Codoceo R, Bajo MA et al. Eating behavior disorders in uremia: a question of balance in appetite regulation. Semin Dial 2004; 17:44-52
18. Hiroshige K, Sonta T, Suda T et al. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant 2001; 16:1856-1862
19. Van Vlem B, Schoonjans R, Vanholder R et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 962-968
20. Aguilera A, Bajo MA, Espinoza M et al. Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. Am J Kidney Dis 2003; 42: 787-796
21. el-Lakany S, Eagon PK, Gavaler JS et al. Gastrointestinal function, morphology, and immune status in uremia. Nutrition 1990; 6: 461468
22. Monteon FJ, Laidlaw SA, Shaib JK et al. Energy expenditure in patients with chronic renal failure. Kidney Int 1986; 30: 741-747
23. Schneeweiss B, Graninger W, Stockenhuber F et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 1990; 52: 596-601
24. Castellino P, Solini A, Luzi L et al. Glucose and amino acid metabolism in chronic renal failure: effect of insulin and amino acids. Am J Physiol 1992; 262: F168-F176
25. Harty J, Conway L, Keegan M et al. Energy metabolism during CAPD: a controlled study. AdvPeritDial 1995; 11: 229-233
26. Cuppari L, de Carvalho AB, Avesani CM et al. Increased resting energy expenditure in hemodialysis patients with severe hyperparathy- roidism. J Am Soc Nephrol 2004; 15: 2933-2939
27. Bazanelli AP, Kamimura MA, da Silva CB et al. Resting energy expenditure in peritoneal dialysis patients. Perit Dial Int 2006; 26: 697-704
28. Kamimura MA, Draibe SA, Avesani CM et al. Resting energy expenditure and its determinants in hemodialysis patients. Eur J Clin Nutr 2007;61:362-367
29. Kamimura MA, Draibe SA, Dalboni MA et al. Serum and cellular interleukin-6 in haemodialysis patients: relationship with energy expenditure. Nephrol Dial Transplant 2007; 22: 839-844
30. Horacek J, Sulkova SD, Fortova M et al. Resting energy expenditure and thermal balance during isothermic and thermoneutral haemodialysis heat production does not explain increased body temperature during haemodialysis. Nephrol Dial Transplant 2007; 22: 3553-3560
31. Barazzoni R, Zanetti M, Stulle M et al. Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non- diabetic maintenance hemodialysis patients. Clin Nutr 2008; 27: 142-149
32. Neyra R, Chen KY, Sun M et al. Increased resting energy expenditure in patients with end-stage renal disease. JPEN J Parenter Enteral Nutr 2003;27:36-42
33. Ikizler TA, Wingard RL, Sun M et al. Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol 1996; 7: 26462653
34. Kogirima M, Sakaguchi K, Nishino K et al. Low resting energy expenditure in middle-aged and elderly hemodialysis patients with poor nutritional status. J Med Invest 2006; 53: 34-41
35. Wang AY, Sea MM, Tang N et al. Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients. J Am Soc Nephrol 2004; 15: 3134-3143
36. Adrogue HJ. Glucose homeostasis and the kidney. Kidney Int 1992; 42:1266-1282
37. Bagdade JD, Porte D Jr, Bierman EL. Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med 1968; 279:181-185
38. Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 2006; 290: F262-F272
39. Dasgupta A, Kenny MA, Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: possible deficiency of essential fatty acids. Clin Physiol Biochem 1990; 8: 238-243
40. Hurot JM, Cucherat M, Haugh M et al. Effects of l-carnitine supplementation in maintenance hemodialysis patients: a systematic review. JAm Soc Nephrol 2002; 13: 708-714
41. Cano NJ, Aparicio M, Brunori G et al. ESPEN guidelines on par- enteral nutrition: adult renal failure. Clin Nutr 2009; 28: 401-414
42. Tizianello A, De Ferrari G, Garibotto G et al. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 1980; 65: 1162-1173
43. Alvestrand A, Furst P, Bergstrom J. Intracellular amino acids in uremia. Kidney Int Suppl 1983; 16: S9-16
44. Deferrari G, Garibotto G, Robaudo C et al. Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency. Am J Clin Nutr 1988; 48: 72-83
45. Cupisti A, Baker F, Brown J et al. Effects of acid loading on serum amino acid profiles and muscle composition in normal fed rats. Clin Sci 1993; 85: 445-449
46. Adey D, Kumar R, McCarthy JT et al. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab 2000; 278: E219-E225
47. Goodship TH, Mitch WE, Hoerr RA et al. Adaptation to low-protein diets in renal failure: leucine turnover and nitrogen balance. J Am Soc Nephrol 1990; 1: 66-75
48. Garibotto G, Russo R, Sofia A et al. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 1994;45:1432-1439
49. Giordano M, De Feo P, Lucidi P et al. Increased albumin and fib- rinogen synthesis in hemodialysis patients with normal nutritional status. J Am Soc Nephrol 2001; 12: 349-354
50. Kaysen GA, Dubin JA, Muller HG et al. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 2004; 65: 1408-1415
51. Mitch WE. Mechanisms causing loss of lean body mass in kidney disease. Am J Clin Nutr 1999; 67: 359-366
52. de Mutsert R, Grootendorst DC, Indemans F et al. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009; 19:127-135
53. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
54. Fouque D. Therapeutic use of growth factors in renal disease. In: Kopple JD, Massry SG (eds). Nutritional Management of Renal Disease. Baltimore: William and Wilkins, 1997, 777-798
55. Brungger M, Hulter HN, Krapf R. Effect of chronic metabolic aci- dosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans. Kidney Int 1997; 51:216221
56. Baumann G, Reza P, Chatterton R et al. Plasma estrogens, androgens, and von Willebrand factor in men on chronic hemodialysis. IntJArtif Organs 1988; 11: 449-453
57. Perez-Flores I, Coronel F, Cigarran S et al. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis. AdvPeritDial 2007; 23: 140-143
58. Wang AY, Woo J, Wang M et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20: 396-403
59. Guzzo I, Mancini E, Kengne Wafo S et al. Residual renal function and nutrition in young patients on chronic hemodialysis. Pediatr Nephrol 2009; 24: 1391-1397
60. Chauveau P, Nguyen H, Combe C et al. Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005; 45: 565-571
61. David S, Kumpers P, Eisenbach GM et al. Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant 2009; 24: 2232-2240
62. Cano NJ, Fouque D, Roth H et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. JAm Soc Nephrol 2007; 18:2583-2591
63. Carrero JJ, Qureshi AR, Axelsson J et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 2007; 85: 695-701
64. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. AmJClinNutr 1981; 34:2540-2545
65. Cano NJ, Miolane-Debouit M, Leger J et al. Assessment of body protein: energy status in chronic kidney disease. Semin Nephrol2009; 29:59-66
66. Qureshi AR, Alvestrand A, Danielsson A et al. Factors predicting malnutrition in hemodialysis patients: a cross- sectional study. Kid- neyInt 1998; 53:773-782
67. Wang AY, Sea MM, Ho ZS et al. Evaluation of handgrip strength as a nutritional marker and prognostic indicator in peritoneal dialysis patients. Am J Clin Nutr 2005; 81: 79-86
68. Locatelli F, Fouque D, Heimburger O et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant 2002;17:563-572
69. Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-1218
70. Wang AY, Sea MM, Ip R et al. Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 2002; 76: 569-576
71. Rammohan M, Kalantar-Zadeh K, Liang A et al. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. JRen Nutr 2005; 15: 345355
72. Ashby DR, Ford HE, Wynne KJ et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. KidneyInt 2009; 76: 199-206
73. Veeneman JM, Kingma HA, Boer TS et al. Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 2003; 284: E954-E965
74. Pupim LB, Flakoll PJ, Brouillette JR et al. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodial- ysis patients. J Clin Invest 2002; 110: 483-492
75. Delarue J, Maingourd C, Objois M et al. Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysis patients. Kidney Int 1999; 56: 1934-1943
76. Tjiong HL, Van Den Berg JW, Wattimena JL et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol 2005; 16: 1486-1493
77. Leon JB, Majerle AD, Soinski JA et al. Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr 2001; 11:9-15
78. Prasad N, Gupta A, Sinha A et al. Changes in nutritional status on follow-up of an incident cohort of continuous ambulatory peritoneal dialysis patients. J Ren Nutr 2008; 18: 195-201
79. Stratton RJ, Bircher G, Fouque D et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis 2005; 46: 387-405
80. Acchiardo S, Moore L, Cockrell S. Effect of essential amino acids (EAA) on chronic hemodialysis (CHD) patients (PTS). Trans Am Soc Artif Intern Organs 1982; 28: 608-614
81. Allman MA, Stewart PM, Tiller DJ et al. Energy supplementation and the nutritional status of hemodialysis patients. Am J Clin Nutr 1990;51:558-562
82. Tietze IN, Pedersen EB. Effect of fish protein supplementation on aminoacid profile and nutritional status in haemodialysis patients. Nephrol Dial Transplant 1991; 6: 948-954
83. Eustace JA, Coresh J, Kutchey C et al. Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbu- minemia. Kidney Int 2000; 57: 2527-2538
84. Sharma M, Rao M, Jacob S et al. A controlled trial of intermittent enteral nutrient supplementation in maintenance hemodialysis patients. J Ren Nutr 2002; 12: 229-237
85. Heaf JG, Honore K, Valeur D et al. The effect of oral protein supplements on the nutritional status of malnourished CAPD patients. Perit Dial Int 1999; 19: 78-81
86. Teixido-Planas J, Ortiz A, Coronel F et al. Oral protein-energy supplements in peritoneal dialysis: a multicenter study. Perit Dial Int 2005;25:163-172
87. Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2005; 25: 173-180
88. Guarnieri GF, Ranieri F, Toigo G et al. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.AmJClinNutr 1980; 33: 1489-1492
89. Wolfson M, Foulks CJ. Intradialytic parenteral nutrition: a useful therapy? Nutr Clin Pract 1996; 11: 5-11
90. Cano N, Labastie-Coeyrehourq J, Lacombe P et al. Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr 1990; 52: 726-730
91. Navarro JF, Mora C, Leon C et al. Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradi- alytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr 2000;71:765-773
92. Wang T, Lindholm B. Peritoneal dialysis solutions. Perit Dial Int 2001; 21(Suppl 3): S89-S95
93. Mehrotra R, Kopple JD. Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis. Adv Ren Replace Ther 2003; 10: 194-212
94. Kopple JD, Bernard D, Messana J et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47:1148-1157
95. Li FK, Chan LY, Woo JC et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 2003; 42: 173-183
96. Pupim LB, Flakoll PJ, Levenhagen DK et al. Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 2004; 286: E589-E597
97. Sakkas GK, Sargeant AJ, Mercer TH et al. Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training. Nephrol Dial Transplant 2003; 18: 1854-1861
98. Johansen KL, Painter PL, Sakkas GK et al. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol 2006; 17: 23072314
99. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nan- drolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 1999; 281: 1275-1281
100. Galland R, Traeger J, Arkouche W et al. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int2001; 60: 1555-1560
101. Fouque D, Peng SC, Shamir E et al. Recombinant human insulinlike growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 2000; 57: 646-654
102. Feldt-Rasmussen B, Lange M, Sulowicz W et al. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol 2007; 18:2161-2171
103. Biolo G, Ciocchi B, Bosutti A et al. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. Am J Kidney Dis 2002;40:1162-1172
104. Kalantar-Zadeh K, Block G, McAllister CJ et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299-307
105. Van V, Schoonjans RS, Struijk DG et al. Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit Dial Int 2002;22:32-38